Should patients get a say in deciding whether a drug is cost-effective?

Should patients get a say in deciding whether a drug is cost-effective?

A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number

By KATE SHERIDAN

HADLEY GREEN FOR STAT

ICER, a nonprofit that works to evaluate the cost-effectiveness of drugs, includes patient perspectives in its analyses — to a point.

READ MORE